Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 10.92 HKD
Market Cap: 23.2B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Genscript Biotech Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genscript Biotech Corp
Cost of Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Cost of Revenue
-$468.1m
CAGR 3-Years
-41%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cost of Revenue
-ÂĄ23.3B
CAGR 3-Years
-23%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cost of Revenue
-ÂĄ7.7B
CAGR 3-Years
-25%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cost of Revenue
-ÂĄ10.5B
CAGR 3-Years
-38%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cost of Revenue
-ÂĄ4.4B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-35%
W
WuXi XDC Cayman Inc
HKEX:2268
Cost of Revenue
-ÂĄ1.6B
CAGR 3-Years
-161%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genscript Biotech Corp's Cost of Revenue?
Cost of Revenue
-468.1m USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Cost of Revenue amounts to -468.1m USD.

What is Genscript Biotech Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-41%

Over the last year, the Cost of Revenue growth was -15%. The average annual Cost of Revenue growth rates for Genscript Biotech Corp have been -41% over the past three years , -41% over the past five years .

Back to Top